Target intelligence / Profile preview

DNA Crosslinking via Oxaliplatin

Molecular classification
DNA, DNA Adduct, Chemotherapeutic target
01

Overview

DNA crosslinking via oxaliplatin refers to the formation of covalent bonds between DNA strands or within a single strand, induced by the platinum-based chemotherapeutic agent oxaliplatin. This process disrupts essential cellular functions such as DNA replication and transcription, ultimately leading to cell death. Oxaliplatin primarily induces intrastrand crosslinks, especially between adjacent guanine bases, but also forms interstrand crosslinks and adducts. The platinum atom in oxaliplatin binds mainly at the N7 position of guanine residues. These adducts bend the double helix, inhibiting replication and transcription. Nucleotide excision repair is primarily responsible for removing oxaliplatin-induced lesions. The cytotoxic effect resulting from this target mechanism underpins the clinical use of oxaliplatin against cancers.

Other names
Oxaliplatin-induced DNA AdductsOxaliplatin-DNA CrosslinksDNA damage induced by oxaliplatin
02

Mechanism of action

Formation of DNA intra- and inter-strand crosslinks, primarily at guanine residues, leading to inhibition of DNA replication and transcription and subsequent cell death.

03

Biological functions

DNA replication inhibitionTranscription inhibitionCell cycle arrestApoptosis induction
04

Disease associations

CancerColorectal Cancer
05

Safety considerations

Chemotherapy-related toxicitiesDevelopment of drug resistanceDNA repair mechanisms can reduce efficacy
06

Interacting drugs

Oxaliplatin
07

Biomarkers

XPA levelsMismatch Repair protein statusAlkaline Comet Assay results

Beyond the preview

Go deeper on DNA Crosslinking via Oxaliplatin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA Crosslinking via Oxaliplatin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call